A Phase 1 Study of ANJ900 Chinese Healthy Subjects

NCT05151146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ANJ900
DRUG: Metformin IR

Sponsor

Anji Pharma